FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT06609928 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Childhood Acute Myeloid Leukemia
Refractory Childhood Acute Myeloid Leukemia

Interventions

BIOLOGICAL: FOLR1 CAR T-cells
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography Test
DRUG: Fludarabine
PROCEDURE: Pheresis
PROCEDURE: Positron Emission Tomography

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]